Literature DB >> 16760578

Immunonegative "null cell" adenomas and gonadotropin (Gn) subunit (SUs) immunopositive adenomas share frequent expression of multiple transcription factors.

Yudo Ishii1, Masanori Suzuki, Susumu Takekoshi, Noboru Egashira, Michio Yamazaki, Shunsuke Miyai, Naoko Sanno, Akira Teramoto, Robert Yoshiyuki Osamura.   

Abstract

The differentiation of pituitary cells and human pituitary adenomas follow three cell lineages: GH-PRL-TSH, ACTH, and FSH/LH, which are regulated by a combination of various transcription factors and co-factors. We have used RT-PCR and immunohistochemistry to show that immunonegative, "null cell" adenomas are equipped with multiple transcription factors and co-factors. The "null cell" adenomas showed similar frequencies of transcription factors as did the gonadotropin subunit (GnSU)-positive adenomas, with the exception that there were fewer instances of SF1 in the former. We speculate, therefore, that null cell adenomas and GnSU-positive adenomas share common molecular mechanisms in functional differentiation, even though the former do not produce hormones. From the high frequency of various transcription factors, we also speculate that both null cell adenomas and GnSU-positive adenomas are derived from "committed" pituitary progenitor stem cells. The questions, why a certain proportion of these pituitary tumor groups lack hormone production and why they are molecularly more committed to Gn transcription, remain to be further investigated.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16760578     DOI: 10.1385/ep:17:1:35

Source DB:  PubMed          Journal:  Endocr Pathol        ISSN: 1046-3976            Impact factor:   3.943


  41 in total

1.  Reciprocal interactions of Pit1 and GATA2 mediate signaling gradient-induced determination of pituitary cell types.

Authors:  J S Dasen; S M O'Connell; S E Flynn; M Treier; A S Gleiberman; D P Szeto; F Hooshmand; A K Aggarwal; M G Rosenfeld
Journal:  Cell       Date:  1999-05-28       Impact factor: 41.582

2.  Immunohistochemical and ultrastructural study of clinically nonfunctioning pituitary adenomas.

Authors:  D Zhao; Y Tomono; K Tsuboi; T Nose
Journal:  Neurol Med Chir (Tokyo)       Date:  2000-09       Impact factor: 1.742

3.  Gonadotropin-releasing hormone and gonadotropin-releasing hormone receptor messenger ribonucleic acids expression in nontumorous and neoplastic pituitaries.

Authors:  N Sanno; L Jin; X Qian; R Y Osamura; B W Scheithauer; K Kovacs; R V Lloyd
Journal:  J Clin Endocrinol Metab       Date:  1997-06       Impact factor: 5.958

Review 4.  Pit-1 determines cell types during development of the anterior pituitary gland. A model for transcriptional regulation of cell phenotypes in mammalian organogenesis.

Authors:  B Andersen; M G Rosenfeld
Journal:  J Biol Chem       Date:  1994-11-25       Impact factor: 5.157

5.  Characterization of Prophet of Pit-1 gene expression in normal pituitary and pituitary adenomas in humans.

Authors:  Y Nakamura; T Usui; H Mizuta; H Murabe; S Muro; M Suda; K Tanaka; I Tanaka; A Shimatsu; K Nakao
Journal:  J Clin Endocrinol Metab       Date:  1999-04       Impact factor: 5.958

6.  Regulation of growth hormone-releasing hormone receptor messenger ribonucleic acid expression by glucocorticoids in MtT-S cells and in the pituitary gland of fetal rats.

Authors:  H Nogami; K Inoue; H Moriya; A Ishida; S Kobayashi; S Hisano; M Katayama; K Kawamura
Journal:  Endocrinology       Date:  1999-06       Impact factor: 4.736

7.  Conserved amino acid sequences confer nuclear localization upon the Prophet of Pit-1 pituitary transcription factor protein.

Authors:  J Chico Guy; Chad S Hunter; Aaron D Showalter; Timothy P L Smith; Kanokwan Charoonpatrapong; Kyle W Sloop; Joseph P Bidwell; Simon J Rhodes
Journal:  Gene       Date:  2004-07-21       Impact factor: 3.688

8.  Functional difference between Ad4BP and ELP, and their distributions in steroidogenic tissues.

Authors:  K Morohashi; H Iida; M Nomura; O Hatano; S Honda; T Tsukiyama; O Niwa; T Hara; A Takakusu; Y Shibata
Journal:  Mol Endocrinol       Date:  1994-05

Review 9.  Pituitary gland.

Authors:  E Horvath; K Kovacs
Journal:  Pathol Res Pract       Date:  1988-04       Impact factor: 3.250

10.  Expression of an orphan nuclear receptor DAX-1 in human pituitary adenomas.

Authors:  S Ikuyama; Y M Mu; K Ohe; H Nakagaki; T Fukushima; R Takayanagi; H Nawata
Journal:  Clin Endocrinol (Oxf)       Date:  1998-05       Impact factor: 3.478

View more
  2 in total

1.  ACTH and alpha-subunit are co-expressed in rare human pituitary corticotroph cell adenomas proposed to originate from ACTH-committed early pituitary progenitor cells.

Authors:  Masanori Suzuki; Noboru Egashira; Hanako Kajiya; Takeo Minematsu; Susumu Takekoshi; Shigeyuki Tahara; Naoko Sanno; Akira Teramoto; Robert Yoshiyuki Osamura
Journal:  Endocr Pathol       Date:  2008       Impact factor: 3.943

2.  Long non-coding RNA C5orf66-AS1 is downregulated in pituitary null cell adenomas and is associated with their invasiveness.

Authors:  Guoqiang Yu; Chuzhong Li; Weiyan Xie; Zhuang Wang; Hua Gao; Lihua Cao; Lingtong Hao; Yazhuo Zhang
Journal:  Oncol Rep       Date:  2017-06-22       Impact factor: 3.906

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.